What measures can be taken to mitigate the side effects of GLP-1 receptor agonists while maintaining their efficacy for weight loss in patients?

GLP-1 receptor agonists are effective for weight loss but often cause gastrointestinal side effects. Strategies like dose titration and dietary adjustments can help mitigate these while maintaining efficacy.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-11
DOI
https://doi.org/10.5281/zenodo.24137044
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What measures can be taken to mitigate the side effects of GLP-1 receptor agonists while maintaining their efficacy for weight loss in patients?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Obesity Treatment
article

What measures can be taken to mitigate the side effects of GLP-1 receptor agonists while maintaining their efficacy for weight loss in patients?

Tripdatabase
article en

Abstract

GLP-1 receptor agonists are effective for weight loss but often cause gastrointestinal side effects. Strategies like dose titration and dietary adjustments can help mitigate these while maintaining efficacy.

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Obesity Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What measures can be taken to mitigate the side effects of GLP-1 receptor agonists while maintaining their efficacy for weight loss in patients? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS